Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel hybrids of benzothiazole-1,3,4-oxadiazole-4-thiazolidinone: Synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment
Rubina Bhutani, Dharam Pal Pathak, Garima Kapoor, et al.
Bioorganic Chemistry (2018) Vol. 83, pp. 6-19
Closed Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Identification of 1,3,4-oxadiazolyl-containing β-carboline derivatives as novel α-glucosidase inhibitors with antidiabetic activity
Di Xiao, Li Lu, Bingwen Liang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115795-115795
Closed Access | Times Cited: 42
Design, synthesis and ADMET prediction of bis-benzimidazole as anticancer agent
Mohammad Rashid
Bioorganic Chemistry (2020) Vol. 96, pp. 103576-103576
Closed Access | Times Cited: 97
1,3,4-Oxadiazole-containing hybrids as potential anticancer agents: Recent developments, mechanism of action and structure-activity relationships
Swarnagowri Nayak, Santosh L. Gaonkar, Ebraheem Abdu Musad, et al.
Journal of Saudi Chemical Society (2021) Vol. 25, Iss. 8, pp. 101284-101284
Open Access | Times Cited: 70
Benzothiazole sulfonate derivatives bearing azomethine: Synthesis, characterization, enzyme inhibition, and molecular docking study
Adem Korkmaz, Ercan Bursal
Journal of Molecular Structure (2022) Vol. 1257, pp. 132641-132641
Closed Access | Times Cited: 42
Oxadiazole: A highly versatile scaffold in drug discovery
Nisheeth C. Desai, Jahnvi D. Monapara, Aratiba M. Jethawa, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 9
Closed Access | Times Cited: 35
Functionalized Triazoles: Design, Synthesis and Chemical Characterization of 1,2,3-triazolylmethylthio-1,3,4-oxadiazole derivatives as Insecticidal and Antibacterial Agents
Hany M. Abd El‐Lateef, Mai M. Khalaf, Mohamed Gouda, et al.
Journal of the Indian Chemical Society (2025) Vol. 102, Iss. 2, pp. 101578-101578
Closed Access
In Silico and In Vivo Evaluation of Novel 2-Aminobenzothiazole Derivative Compounds as Antidiabetic Agents
J. A. SALAZAR, Miguel Ángel Serra Valdés, Alejandro Canales Cruz, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 909-909
Open Access
One-Pot, for the Green Preparation of Benzimidazoles and 2,3-Dihydroquinazolin-4(1H)-ones Catalyzed by In2O3 NPs/Glycerol
Fadhil Faez Sead, Vicky Jain, Anjan Kumar, et al.
Journal of Inorganic and Organometallic Polymers and Materials (2025)
Closed Access
A first-principles evaluation on the interaction of 1,3,4-oxadiazole with pristine and B-, Al-, Ga-doped C60 fullerenes
İskender Muz, Mustafa Kurban
Journal of Molecular Liquids (2021) Vol. 335, pp. 116181-116181
Closed Access | Times Cited: 49
Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition
Lalitha Gummidi, Nagaraju Kerru, Oluwakemi Ebenezer, et al.
Bioorganic Chemistry (2021) Vol. 115, pp. 105210-105210
Closed Access | Times Cited: 49
π–π Noncovalent Interaction Involving 1,2,4- and 1,3,4-Oxadiazole Systems: The Combined Experimental, Theoretical, and Database Study
Sergey V. Baykov, Alexander S. Mikherdov, Alexander S. Novikov, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5672-5672
Open Access | Times Cited: 48
Synthesis of novel 5-(2,5-bis(2,2,2-trifluoroethoxy)phenyl)-1,3,4-oxadiazole-2-thiol derivatives as potential glucosidase inhibitors
Ramesh S. Gani, Avinash K. Kudva, Karabasanagouda Timanagouda, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105046-105046
Closed Access | Times Cited: 40
Synthesis of Novel 2,3-Dihydro-1,5-Benzothiazepines as α-Glucosidase Inhibitors: In Vitro, In Vivo, Kinetic, SAR, Molecular Docking, and QSAR Studies
Rabia Mehmood, Ehsan Ullah Mughal, Eslam B. Elkaeed, et al.
ACS Omega (2022) Vol. 7, Iss. 34, pp. 30215-30232
Open Access | Times Cited: 30
Design, synthesis, characterization, molecular docking studies and anticancer activity evaluation of novel hydrazinecarbothioamide, 1,2,4-triazole-3-thione, 4-thiazolidinone and 1,3,4-oxadiazole derivatives
Efe Doğukan Dincel, Çiğdem Akdağ, Tülay Kayra, et al.
Journal of Molecular Structure (2022) Vol. 1268, pp. 133710-133710
Closed Access | Times Cited: 26
Synthesis, crystal structure and evaluation of anticancer activities of some novel heterocyclic compounds based on thymol
Yassine Laamari, Abdoullah Bimoussa, Mourad Fawzi, et al.
Journal of Molecular Structure (2023) Vol. 1278, pp. 134906-134906
Open Access | Times Cited: 16
Recent Advances in the Application of 2‐Aminobenzothiazole to the Multicomponent Synthesis of Heterocycles
Ramin Javahershenas, Jianlin Han, Mosstafa Kazemi, et al.
ChemistryOpen (2024)
Open Access | Times Cited: 5
In vitro and in silico studies of fluorinated 2,3‐disubstituted thiazolidinone‐pyrazoles as potential α‐amylase inhibitors and antioxidant agents
D. Ganavi, Ramith Ramu, Vasantha Kumar, et al.
Archiv der Pharmazie (2021) Vol. 355, Iss. 3
Closed Access | Times Cited: 33
Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics
Archana Sharma, Diksha Sharma, Neha Saini, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 847-889
Open Access | Times Cited: 13
Synthesis, in vitro and in silico anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives
Milica Z Stevanović, Sofija S. Bekić, Edward T. Petri, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 11, pp. 1127-1145
Closed Access | Times Cited: 3
Probing benzenesulfonamide–thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II
Mona A. Gamal, Samar H. Fahim, Simone Giovannuzzi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116434-116434
Closed Access | Times Cited: 3
Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: Design, synthesis, in vitro bio-evaluation targeting DPP-4, α-glucosidase, and α-amylase with in-silico ADMET and docking simulation
Hamdy Khamees Thabet, Yousry A. Ammar, Mohd Imran, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107671-107671
Closed Access | Times Cited: 3
Advances in 2‐substituted benzothiazole scaffold‐based chemotherapeutic agents
Kashif Haider, Sara Rehman, Ankita Pathak, et al.
Archiv der Pharmazie (2021) Vol. 354, Iss. 12
Closed Access | Times Cited: 26
An efficient One-pot three-component synthesis, Molecular docking, ADME and DFT predictions of new series Thiazolidin-4-one derivatives bearing a Sulfonamide moiety as potential Antimicrobial and Antioxidant agents
Sangar Ali Hassan
Egyptian Journal of Chemistry (2022)
Open Access | Times Cited: 20
Heterocyclic compounds as a magic bullet for diabetes mellitus: a review
Umme Farwa, Muhammad Asam Raza
RSC Advances (2022) Vol. 12, Iss. 35, pp. 22951-22973
Open Access | Times Cited: 20
Heterocyclic Compounds as Dipeptidyl Peptidase-IV Inhibitors with Special Emphasis on Oxadiazoles as Potent Anti-Diabetic Agents
Badrud Duza Mohammad, Mirza Shahed Baig, Neeraj Bhandari, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 6001-6001
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top